We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Sperm Analyzer Offers Enhanced Performance, Flexibility, and Standardization

By LabMedica International staff writers
Posted on 28 Jul 2015
A new automated sperm-quality analyzer includes enhancement features such as a high-definition touch-screen interface, expanded testing options, and state-of-the-art digital magnification with “click-to-mark” interface. More...
The analyzer will be exhibited by Medical Electronic Systems (MES; Los Angeles, CA, USA) at the Clinical Lab Expo of AACC 2015 (July 26-30; Atlanta, GA, USA).

The “SQA-Vision” analyzer was developed based on 10 years of market feedback and is positioned to augment MES’s line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

“MES has placed greater than 3,750 semen analyzers globally in over 45 countries. This market penetration provided us with the unique opportunity to develop the SQA-Vision based on a wealth of customer feedback. The SQA-Vision will profoundly impact the way semen analysis is conducted in laboratories worldwide with rapid, standardized and accurate test results, customized reporting and greatly expanded testing options which strictly adhere to WHO guidelines,” said Eric Carver, General Manager.

MES developed the SQA-Vision as an intuitive tool for fertility screening, post-vasectomy follow-up, sperm banking, research or detailed IVF assessment. In addition to the predecessor’s testing modes (Fresh, Washed, Frozen, and Post Vasectomy), the SQA-Vision now includes: Density Gradient, Swim Up, Longevity, and Vitality testing options. It also provides a high-resolution visual interface, barcode scanning technology, built-in LIS capability and click-to-mark counters for assessing both sperm vitality and conducting full differential morphology.

“The beauty of the new SQA-Vision is the blend of updated technology, flexibility, and standardized testing. Depending on how semen analysis is conducted in your laboratory, the Vision can be set-up to operate in a wide range of modes. From fully automated routine screening to intensive IVF workups,” said Marcia Deutsch, CEO.

Related Links:

Medical Electronic Systems
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Portable POCT Blood Gas Analyzer
BD100
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.